School of Agriculture, Food and Wine, Waite Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
IUBMB Life. 2022 Dec;74(12):1232-1252. doi: 10.1002/iub.2664. Epub 2022 Jul 26.
Although the prevalence of antibiotic resistance is increasing at an alarming rate, there are a dwindling number of effective antibiotics available. Thus, the development of novel antibacterial agents should be of utmost importance. Peptidoglycan biosynthesis has been and is still an attractive source for antibiotic targets; however, there are several components that remain underexploited. In this review, we examine the enzymes involved in the biosynthesis of one such component, UDP-N-acetylglucosamine, an essential building block and precursor of bacterial peptidoglycan. Furthermore, given the presence of a similar biosynthesis pathway in eukaryotes, we discuss the current knowledge on the differences and similarities between the bacterial and eukaryotic enzymes. Finally, this review also summarises the recent advances made in the development of inhibitors targeting the bacterial enzymes.
尽管抗生素耐药性的流行率正在以惊人的速度增长,但可用的有效抗生素数量却在逐渐减少。因此,开发新型抗菌药物应该是最重要的。肽聚糖生物合成一直是并且仍然是抗生素靶标的有吸引力的来源;然而,有几个成分仍然未被充分利用。在这篇综述中,我们研究了参与合成一种这样的成分的酶,即 UDP-N-乙酰葡萄糖胺,它是细菌肽聚糖的必需构建块和前体。此外,鉴于真核生物中存在类似的生物合成途径,我们讨论了细菌和真核酶之间的差异和相似之处的现有知识。最后,本文还总结了针对细菌酶开发抑制剂的最新进展。